Melax Tech Leadership
Chief Executive Officer
Andre is an experienced healthcare executive with a proven track record in creating strategic partnerships, scaling startups, large enterprise sales agreements, business development and product innovation.
Frank Manion, PhD
VP for Innovation
Dr. Manion, VP for Innovation, has held executive positions in biomedical informatics support at two major NCI-designated comprehensive cancer centers. He served as Chief Technology Officer and Deputy CIO at the Fox Chase Cancer Center.
Chief Technology Officer
Jingqi Wang serves as the Chief Technology Officer at Melax Tech, leading the NLP development team. He has ten years of working experience as a software developer before he joined Melax.
Hao Ding, PhD
Director of Operations
A biophysicist by training, Dr. Ding was fascinated by natural language processing, machine learning, and the impact of new technology that will bring to the healthcare industry. Hao has been passionate about expanding business development.
Jingcheng Du, PhD
Director of NLP Research
Dr. Du serves as the Director of Natural Language Processing at Melax Tech, and Adjunct Assistant Professor at University of Texas Health School of Biomedical Informatics, additionally. Dr. Du earned his Ph.D. in Medical Informatics from UTHealth.
Project Manager and Security Officer
Cynthia Freeney is Melax Tech’s Project Manage and Security Officer. A naturally curious individual, Cynthia has varied experience in the software development space and has held many roles.
Hua Xu, PhD
Dr. Xu is the Founder of Melax Tech. He received his PhD in Biomedical Informatics from Columbia University, and currently is also a part-time professor at The University of Texas Health Science Center at Houston. In the past decade, he has worked on a broad range of challenging NLP topics and clinical NLP methods and systems developed in his lab have been highly recognized. He served as the Chair of AMIA NLP Working Group and currently also leads the NLP Working Group at OHDSI.